ABT-925, also known as A-37203, BSF-201640, DAT-201, Lu-201640, and A-437203, is a selective dopamine D3 receptor (DRD3) antagonist with an approximately 100-fold higher in vitro affinity for dopamine D3 versus D2 receptors. ABT-925 was tested in schizophrenia. ABT-925 is a selective dopamine D3 receptor antagonist with an approximately 100-fold higher in vitro affinity for dopamine D3 versus D2 receptors.
Molecular Weight:
572.6
CAS Number:
[220519-07-3]
Formula:
C24H31F3N6O5S
Target:
Others
T69808
* VAT and and shipping costs not included. Errors and price changes excepted